- Home
- APGE vs ALRM Comparison
APGE vs ALRM Comparison
Compare APGE & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- ALRM
- Stock Information
- Founded
- APGE 2022
- ALRM 2000
- Country
- APGE United States
- ALRM United States
- Employees
- APGE N/A
- ALRM N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- ALRM Computer Software: Prepackaged Software
- Sector
- APGE Health Care
- ALRM Technology
- Exchange
- APGE Nasdaq
- ALRM Nasdaq
- Market Cap
- APGE 3.0B
- ALRM 2.7B
- IPO Year
- APGE 2023
- ALRM 2015
- Fundamental
- Price
- APGE $47.25
- ALRM $59.85
- Analyst Decision
- APGE Strong Buy
- ALRM Buy
- Analyst Count
- APGE 5
- ALRM 6
- Target Price
- APGE $75.20
- ALRM $65.33
- AVG Volume (30 Days)
- APGE 366.5K
- ALRM 434.1K
- Earning Date
- APGE 11-12-2024
- ALRM 11-07-2024
- Dividend Yield
- APGE N/A
- ALRM N/A
- EPS Growth
- APGE N/A
- ALRM 80.16
- EPS
- APGE N/A
- ALRM 2.31
- Revenue
- APGE N/A
- ALRM $923,824,000.00
- Revenue This Year
- APGE N/A
- ALRM $7.29
- Revenue Next Year
- APGE N/A
- ALRM $5.19
- P/E Ratio
- APGE N/A
- ALRM $25.86
- Revenue Growth
- APGE N/A
- ALRM 6.98
- 52 Week Low
- APGE $16.39
- ALRM $51.87
- 52 Week High
- APGE $72.29
- ALRM $77.29
- Technical
- Relative Strength Index (RSI)
- APGE 35.00
- ALRM 60.27
- Support Level
- APGE $57.85
- ALRM $59.82
- Resistance Level
- APGE $63.50
- ALRM $67.30
- Average True Range (ATR)
- APGE 3.86
- ALRM 1.71
- MACD
- APGE -0.90
- ALRM 0.53
- Stochastic Oscillator
- APGE 4.97
- ALRM 47.39
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices. SaaS & license fees from service providers, who resell these services & pay Alarm.com a monthly subscription, are the sources of revenue for the firm. The majority of revenue is generated in the United States & Canada.